In our previous study, we have shown a methylation gene panel including RASSF1, WIF1, RARB2, and DAPK1 has great potential to be used as a noninvasive and complementary test for NPC early detection in combination with the EBV DNA test 12. This evidence concerns the gene RASSF1 and nasopharyngeal carcinoma.